| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11010575 | Journal of Stroke and Cerebrovascular Diseases | 2018 | 9 Pages |
Abstract
In a single-center registry, 23% of patients with AF treated with a DOAC received an inappropriate dose. Several clinical factors, such as age and the creatinine clearance value, can identify patients at risk of under-treatment with DOACs.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Takao MD, Yoshifusa MD, Koichi MD, Satoshi MD, Yoshio MD, Hitoshi MD, Minoru MD, Masaaki MD,